Showing results (561-570 of 609) with videos related to

Sort By:
Pageof 61
American Journal of Physiology. Endocrinology and Metabolism|March 17, 2011
Deficiency of PTP1B in POMC neurons leads to alterations in energy balance and homeostatic response to cold exposureBart C De Jonghe, Matthew R Hayes, Ryoichi Banno, et al.
Frontiers in Immunology|March 5, 2019
Promiscuous Coxiella burnetii CD4 Epitope Clusters Associated With Human Recall Responses Are Candidates for a Novel T-Cell Targeted Multi-Epitope Q Fever VaccineAnja Scholzen, Guilhem Richard, Leonard Moise, et al.
Cancer|July 5, 2012
Phase 2 trial of daily, oral Polyphenon E in patients with asymptomatic, Rai stage 0 to II chronic lymphocytic leukemiaTait D Shanafelt, Timothy G Call, Clive S Zent, et al.
Frontiers in Immunology|June 2, 2022
Evaluation of a Human T Cell-Targeted Multi-Epitope Vaccine for Q Fever in Animal Models of Coxiella burnetii ImmunityAnn E Sluder, Susan Raju Paul, Leonard Moise, et al.
Scientific Reports|April 5, 2018
Structure-function analysis and therapeutic efficacy of antibodies to fungal melanin for melanoma radioimmunotherapyJ D Nosanchuk, A Jeyakumar, A Ray, et al.
The Journal of General Virology|August 26, 2011
Envelope and pre-membrane protein structural amino acid mutations mediate diminished avian growth and virulence of a Mexican West Nile virus isolateStanley A Langevin, Richard A Bowen, Wanichaya N Ramey, et al.
Biorxiv : the Preprint Server for Biology|November 19, 2025
Neuroinflammatory Stress Preferentially Impacts Synaptic MAPK Signaling and Mitochondria in Excitatory NeuronsClaudia Espinosa-Garcia, Upasna Srivastava, Prateek Kumar, et al.
Molecular Neurodegeneration Advances|April 9, 2026
Neuroinflammatory stress preferentially impacts synaptic MAPK signaling and mitochondria in excitatory neuronsClaudia Espinosa-Garcia, Upasna Srivastava, Prateek Kumar, et al.
The Lancet. Haematology|August 30, 2016
Ofatumumab monotherapy as a consolidation strategy in patients with previously untreated chronic lymphocytic leukaemia: a phase 2 trialPaolo Strati, Mark Lanasa, Timothy G Call, et al.
Nature Communications|October 10, 2018
Ultrasmall targeted nanoparticles with engineered antibody fragments for imaging detection of HER2-overexpressing breast cancerFeng Chen, Kai Ma, Brian Madajewski, et al.
Pageof 61